Membership News

BIVDA CEO Doris-Ann Williams has recently spoken to The Independent, stating that the UK should prepare for a wave of non-COVID deaths from undiagnosed illnesses owing to millions of missed or delayed tests due to the pandemic. Doris-Ann pointed to unreleased BIVDA data which shows that a lack of testing for conditions such as diabetes, heart disease and cancer since…

The OLS Skills Team would like to draw your attention to a survey recently launched by UKRI, looking into the experience of UK-based R&D businesses navigating the UK immigration system, for example when recruiting talent from overseas. OLS will be able to view the responses gathered from individuals in the life sciences sector, so we’d urge you to take the…

Transition into compliance with IVDR necessitates a considerable investment by manufacturers in their Quality Management Systems (QMS) and subsequent certification by Notified Bodies. We are aware that for SMEs in particular this can represent a considerable, sometimes disproportionate, burden. However, one of our SME members has recently successfully completed its Notified Body audit in line with IVDR requirements and has…

On Tuesday Doris-Ann did an interview with BBC News, first broadcast at 9.50am but repeated during the day on the TV and radio. The invitation came to speak on the reported lack of LFTs to the public and the hope that BIVDA would provide clarity on this. Doris-Ann answered the questions using information supplied by Test & Trace beforehand but…

The Cabinet Office has set out new Government measures which will see the exclusion of poor performing suppliers, as the UK departs from EU procurement laws. The plans would see exclusion criteria being changed to better suit the UK’s legal landscape. As a result, suppliers may be excluded from a contract based on their past performance, only where that performance…

As the UK’s first laboratory responder to the COVID-19 pandemic, UKHSA has a unique collection of COVID samples from the onset and throughout the ongoing pandemic. A biobank of UKHSA’s residual samples has been established to provide a vital resource for the curation and distribution of samples to strengthen research, evaluations and diagnostic development in the field. Please contact the…

The Diagnostics Growth Hub connects innovative companies with expertise from the London health and life sciences ecosystem. The Hub supports diagnostic development, evaluation, validation and implementation to place London and the UK as leaders in diagnostic development and scale. BIVDA have recently taken part in an expert scoring group for a funding exercise for Medcity, Collaborate to Innovate. They are…